Eric Lefebvre - 25 Jan 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Eric Lefebvre
Issuer symbol
N/A
Transactions as of
25 Jan 2023
Net transactions value
$0
Form type
4
Filing time
27 Jan 2023, 15:33:22 UTC
Previous filing
25 Jan 2023
Next filing
31 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 25 Jan 2023 Common Stock 25,000 $7.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the underlying shares monthly from January 1, 2023.